beta-Endorphin-induced analgesia is inhibited by synthetic analogs of beta-endorphin.

AUTOR(ES)

Nicolas, P

RESUMO

Competitive antagonism of human beta-endorphin (beta h-EP)-induced analgesia by synthetic beta h-EP analogs with high in vitro opiate receptor binding to in vivo analgesic potency ratio has been demonstrated. A parallel shift of the dose-response curve for analgesia to the right was observed when either beta h-EP or [ Trp27 ] -beta h-EP was coinjected with various doses of [Gln8, Gly31 ]-beta h-EP-Gly-Gly-NH2, [Arg9,19,24,28,29]-beta h-EP, or [ Cys11 ,26, Phe27 , Gly31 ]-beta h-EP. It was estimated that the most potent antagonist, [Gln8, Gly31 ]-beta h-EP-Gly-NH2, is at least 200 times more potent than naloxone.

Documentos Relacionados

• Peptide inhibitor of morphine- and beta-endorphin-induced analgesia.
• beta-endorphin-(1-27) is an antagonist of beta-endorphin analgesia.
• Beta-endorphin-(1-27) is a naturally occurring antagonist to etorphine-induced analgesia.
• Regulation of duodenal bicarbonate secretion during stress by corticotropin-releasing factor and beta-endorphin.
• Isolation and characterization of the opioid peptides from rat pituitary: beta-endorphin.